Mometasone furoate/Oxymetazoline Hydrochloride

莫米松糠酸酯/盐酸羟甲唑啉

Report date: 2022/07/19 16:22:54

Base Information

Drug NameMometasone furoate/Oxymetazoline Hydrochloride

Drug Alias Name盐酸羟甲唑啉/莫米松糠酸酯Oxymetazoline Hydrochloride/Mometasone furoate盐酸羟甲唑啉莫米松糠酸酯Mometasone furoate and Oxymetazoline Hydrochloride莫米松糠酸酯盐酸羟甲唑啉 +[7]

ClassificationSmall molecules > Steroids

Mechanisms of ActionAlpha-1a adrenergic receptor agonistsGlucocorticoid receptor agonists

TargetsGlucocorticoid receptorAlpha-1a adrenergic receptor

Therapy Area/IndicationsRhinitis, Allergic, Seasonal

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsYes Oxymetazoline Hydrochloride Mometasone furoate

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesMerck & Co Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesOrganon & Co

Active IndicationsN/A

Inactive IndicationsRhinitis, Allergic, Seasonal

Other Information

ATC CodeN/A